Via the Antitrust Review, three ABA committees will be presenting a lunch seminar entitled "Who’s Drug is it Anyway? Authorized Generics, Their Role in the Pharmaceutical Marketplace, and the FTC Study" on Thursday, September 14 from noon to 1:30 pm EST. You may attend the seminar in person at Drinker Biddle & Reath’s Washington D.C. office, or you may call in by phone. Additionally, an .mp3 audio recording of the program will be posted at http://www.abanet.org/anitrust/at-bb/bb-audio.shtml. More details are here.
Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Orange Book Blog 
Leave a comment